This Monday, healthcare software provider Phreesia announced the terms for its upcoming IPO. The New York-based patient-intake healthcare software platform provider aims to raise $125 million through offering 7.8 million share (15 percent secondary) at a range of $15 to $17. Assuming the midpoint of the proposed price range, Phreesia’s implied market value will stand at $658 million...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.